NO20181070A1 - - Google Patents
Download PDFInfo
- Publication number
- NO20181070A1 NO20181070A1 NO20181070A NO20181070A NO20181070A1 NO 20181070 A1 NO20181070 A1 NO 20181070A1 NO 20181070 A NO20181070 A NO 20181070A NO 20181070 A NO20181070 A NO 20181070A NO 20181070 A1 NO20181070 A1 NO 20181070A1
- Authority
- NO
- Norway
- Prior art keywords
- fish
- extract
- sophora flavescens
- pharmaceutical composition
- flavescens aiton
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 claims description 65
- 241000246044 Sophora flavescens Species 0.000 claims description 50
- 239000000284 extract Substances 0.000 claims description 45
- 241001674048 Phthiraptera Species 0.000 claims description 43
- 239000000203 mixture Substances 0.000 claims description 35
- 208000030852 Parasitic disease Diseases 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 244000045947 parasite Species 0.000 claims description 17
- 239000004480 active ingredient Substances 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- 241000277331 Salmonidae Species 0.000 claims description 11
- 239000003674 animal food additive Substances 0.000 claims description 10
- NADCVNHITZNGJU-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one Chemical compound CC(C)=CCC1=C(O)C=C(O)C(C(C=2O)=O)=C1OC=2C1=CC=C(O)C=C1 NADCVNHITZNGJU-UHFFFAOYSA-N 0.000 claims description 6
- RJANATGWWPNKAL-UHFFFAOYSA-N 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-(3-methylbut-2-enyl)chromen-4-one Chemical compound CC(C)=CCC=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C=C1 RJANATGWWPNKAL-UHFFFAOYSA-N 0.000 claims description 6
- 206010061217 Infestation Diseases 0.000 claims description 5
- 239000002917 insecticide Substances 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- FQEQMASDZFXSJI-RWMBFGLXSA-N (-)-Anagyrine Natural products C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@@H]2C1 FQEQMASDZFXSJI-RWMBFGLXSA-N 0.000 claims description 3
- ANJTVLIZGCUXLD-BDAKNGLRSA-N (-)-Cytisine Natural products C1NC[C@@H]2CN3C(=O)C=CC=C3[C@H]1C2 ANJTVLIZGCUXLD-BDAKNGLRSA-N 0.000 claims description 3
- LKZDFKLGDGSGEO-UHFFFAOYSA-N 2',8-Di-Me ether,7-O-beta-D-glucuronoside-2',5,7,8-Tetrahydroxyflavone Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)OC(CO)C(O)C1O LKZDFKLGDGSGEO-UHFFFAOYSA-N 0.000 claims description 3
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 claims description 3
- FQEQMASDZFXSJI-UHFFFAOYSA-N Anagyrin Natural products C12CCCCN2CC2C3=CC=CC(=O)N3CC1C2 FQEQMASDZFXSJI-UHFFFAOYSA-N 0.000 claims description 3
- 241000244021 Anisakis simplex Species 0.000 claims description 3
- 241000937961 Benedenia Species 0.000 claims description 3
- 241000531846 Bivagina Species 0.000 claims description 3
- 241000242722 Cestoda Species 0.000 claims description 3
- 241000114702 Cymothoa Species 0.000 claims description 3
- 241000248482 Ichthyophthirius multifiliis Species 0.000 claims description 3
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims description 3
- YKGCBLWILMDSAV-GOSISDBHSA-N Isoxanthohumol Natural products O(C)c1c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c(C/C=C(\C)/C)c(O)c1 YKGCBLWILMDSAV-GOSISDBHSA-N 0.000 claims description 3
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims description 3
- VQYBAEAOOJBSTR-QHSBEEBCSA-N Sophoranol Chemical compound C([C@@H]12)CCC(=O)N1C[C@@]1(O)[C@H]3[C@@H]2CCCN3CCC1 VQYBAEAOOJBSTR-QHSBEEBCSA-N 0.000 claims description 3
- VQYBAEAOOJBSTR-AYRXBEOTSA-N Sophoranol Natural products O=C1N2[C@H]([C@@H]3[C@@H]4[C@](O)(C2)CCCN4CCC3)CCC1 VQYBAEAOOJBSTR-AYRXBEOTSA-N 0.000 claims description 3
- FQEQMASDZFXSJI-YNEHKIRRSA-N anagyrine Chemical compound C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@H]2C1 FQEQMASDZFXSJI-YNEHKIRRSA-N 0.000 claims description 3
- ICFWMXKHGNCJTK-UHFFFAOYSA-N anagyrine Natural products O=C1C=CC=C2C3CC(CC4CCCCN4C3)N12 ICFWMXKHGNCJTK-UHFFFAOYSA-N 0.000 claims description 3
- 208000005067 anisakiasis Diseases 0.000 claims description 3
- 229930017327 cytisine Natural products 0.000 claims description 3
- ANJTVLIZGCUXLD-DTWKUNHWSA-N cytisine Chemical compound C1NC[C@H]2CN3C(=O)C=CC=C3[C@@H]1C2 ANJTVLIZGCUXLD-DTWKUNHWSA-N 0.000 claims description 3
- 229940027564 cytisine Drugs 0.000 claims description 3
- FUSADYLVRMROPL-UHFFFAOYSA-N demethylxanthohumol Natural products CC(C)=CCC1=C(O)C=C(O)C(C(=O)C=CC=2C=CC(O)=CC=2)=C1O FUSADYLVRMROPL-UHFFFAOYSA-N 0.000 claims description 3
- ANJTVLIZGCUXLD-UHFFFAOYSA-N ent-cytisine Natural products C1NCC2CN3C(=O)C=CC=C3C1C2 ANJTVLIZGCUXLD-UHFFFAOYSA-N 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 150000008131 glucosides Chemical class 0.000 claims description 3
- LKZDFKLGDGSGEO-UJECXLDQSA-N kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O[C@H](CO)[C@@H](O)[C@@H]1O LKZDFKLGDGSGEO-UJECXLDQSA-N 0.000 claims description 3
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 claims description 3
- 229930014456 matrine Natural products 0.000 claims description 3
- CULUKMPMGVXCEI-VHSXEESVSA-N n-methylcytisine Chemical compound C12=CC=CC(=O)N2C[C@@H]2CN(C)C[C@H]1C2 CULUKMPMGVXCEI-VHSXEESVSA-N 0.000 claims description 3
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 claims description 3
- 229930015582 oxymatrine Natural products 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- ORXQGKIUCDPEAJ-YRNVUSSQSA-N xanthohumol Chemical compound COC1=CC(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ORXQGKIUCDPEAJ-YRNVUSSQSA-N 0.000 claims description 3
- UVBDKJHYMQEAQV-UHFFFAOYSA-N xanthohumol Natural products OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)C=CC1=CC=C(O)C=C1 UVBDKJHYMQEAQV-UHFFFAOYSA-N 0.000 claims description 3
- 235000008209 xanthohumol Nutrition 0.000 claims description 3
- 241001247232 Caligidae Species 0.000 claims description 2
- 241001611011 Caligus Species 0.000 claims description 2
- 241001611004 Caligus rogercresseyi Species 0.000 claims description 2
- 241001247233 Lepeophtheirus Species 0.000 claims description 2
- 241001247234 Lepeophtheirus salmonis Species 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- -1 kaurinone Chemical compound 0.000 claims description 2
- 238000000638 solvent extraction Methods 0.000 claims description 2
- 235000019688 fish Nutrition 0.000 description 54
- 241000972773 Aulopiformes Species 0.000 description 20
- 235000019515 salmon Nutrition 0.000 description 20
- 230000000694 effects Effects 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000000605 extraction Methods 0.000 description 10
- 230000003071 parasitic effect Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000009313 farming Methods 0.000 description 6
- 239000013535 sea water Substances 0.000 description 6
- 238000009360 aquaculture Methods 0.000 description 5
- 244000144974 aquaculture Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000277269 Oncorhynchus masou Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000277263 Salmo Species 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241001519451 Abramis brama Species 0.000 description 2
- 241000881711 Acipenser sturio Species 0.000 description 2
- 241000473391 Archosargus rhomboidalis Species 0.000 description 2
- 241001417984 Cynoglossidae Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 241000723298 Dicentrarchus labrax Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001481825 Morone saxatilis Species 0.000 description 2
- 241000277334 Oncorhynchus Species 0.000 description 2
- 241001282110 Pagrus major Species 0.000 description 2
- 241000269799 Perca fluviatilis Species 0.000 description 2
- 241000269908 Platichthys flesus Species 0.000 description 2
- 241000269980 Pleuronectidae Species 0.000 description 2
- 241000277293 Salvelinus alpinus Species 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 241001582957 Sebastes schlegelii Species 0.000 description 2
- 241000276699 Seriola Species 0.000 description 2
- 241001417495 Serranidae Species 0.000 description 2
- 241000500840 Spondyliosoma cantharus Species 0.000 description 2
- 241000276707 Tilapia Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 241001233037 catfish Species 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LTTQKYMNTNISSZ-MWTRTKDXSA-N (2S)-(-)-kurarinone Chemical compound C1([C@H]2OC=3C(C[C@@H](CC=C(C)C)C(C)=C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1O LTTQKYMNTNISSZ-MWTRTKDXSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241001098054 Pollachius pollachius Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- XQVFLLMCNGKXSM-UHFFFAOYSA-N kurarinone Natural products COc1cc(O)c(C(CC=C(C)C)C(=C)C)c2OC(CC(=O)c12)c3ccc(O)cc3O XQVFLLMCNGKXSM-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- KDADHLPROOOPIC-UHFFFAOYSA-N neokurarinol Natural products COc1cc(O)ccc1C1CC(=O)c2c(OC)cc(O)c(CC(CCC(C)(C)O)C(C)=C)c2O1 KDADHLPROOOPIC-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
- Feed For Specific Animals (AREA)
Description
COMPOSITIONS FOR PREVENTING OR TREATING FISH PARASITIC INFECTIONS, INCLUDING EXTRACTS OF SOPHORA FLAVESCENS AITON OR
FRACTIONS THEREOF
[Technical Field]
[1] The present invention relates to a composition for preventing or treating a parasitic infectious disease of fish, comprising an extract of Sophora flavescens Aiton as an active ingredient, more specifically, a pharmaceutical composition for preventing or treating a parasitic infectious disease of fish, comprising the extract of Sophora flavescens Aiton, a fraction thereof or a compound isolated therefrom as an active ingredient, a feed additive composition for preventing or improving, and a method for preventing or treating a parasitic infectious disease of a fish, comprising the step of putting the composition directly into a fish or in a farm.
[Background Art]
[2] Worldwide, fish aquaculture is an alternative to the depletion of fishery resources, focusing on fish species that are favorable to food and have excellent merchantability, and among them, salmon contains many unsaturated fatty acids such as DHA and EPA which are beneficial to our body, and is excellent in taste and is the most preferred fish species in the world. The world's largest salmon aquaculture country is Norway, followed by Britain, Chile, Canada and Australia. The common point of salmon cultivation stations is that they are located in the waters where cold seawater flows. The global salmon market is estimated at 4.3 million tons and 20 trillion won a year, including about 60 trillion won if it includes processing market.
[3] In Korea, Salmonidae, Cherry salmon is mainly cultivated, and Cherry salmon is a salmonidae living in rivers and seas of Korea, China, Japan and Russia, and the size is 60 cm smaller than 1 meter of Norwegian salmon. We call it Shima salmon which is Japanese name. That is, Salmonidae trout inhabitats in Korea, but they do not use the name salmon but cherry salmon (trout). Trout fishing and festivals in winter are famous. In Korea, the development of freshwater-based inland water trout farming has developed, and in 2015 it was the 50th anniversary of trout farming. Meanwhile, salmon can be classified into Pacific salmon and Atlantic salmon. In Korea, silver salmon belonging to Pacific salmon is being tried. Atlantic salmon, on the other hand, are cultivated in large scale in the North Sea fjord such as Norway, and in the Pacific coast in Chile and Canada. Korea is still in trial study.
[4] Norway's most known form of salmon, Marine Harvest, succeeded in salmon farming in the 1960s, and small businesses with local fishermen have grown into global companies today. Currently, the largest salmon farming company in the world, hatches 100 million salmon eggs per year and earns about 3 trillion won in salmon farming.
[5] However, the biggest problem of the current aquaculture industry is mortality rate, which is more than 20%, and the major causes are the incidence of intractable diseases and infections (viral, bacterial, parasitic) due to the rise in water temperature, and reduction of the effects of medicines treatment. In particular, "sea lice" is essential for farms with high breeding density, and salmon with sea lice has many side effects due to physical and chemical damage. 'Sea lice' is an external parasite that is largely parasitic to Atlantic salmon farmed in Norway as well as Scotland and Canada. Once a sea lice occurs, it can spread explosively. Specifically, sea lice for fish are external parasites that live on the mucus, epidermal tissue or blood of the host fish. The protein components present in the sea lice are attached to the in vitro tissues of the fish and become parasitic life as a host. When sea lice are parasitized on fish, they amplify inflammation, pathogens, etc., and they have a serious problem that the mortality rate increases and the fish population decreases. In Norway and Scotland, there are cases where salmon are killed by 30 to 40% because fish are concentrated and cultivated intensively within the cage farm.
[6] In the past, farmers tried to solve this problem by putting insecticides on feed for salmon farming, but in recent years, sea lice resistant to this chemical has appeared. Currently, Marine Harvest is trying to reduce the number of sea lice by introducing a feeder fish which naturally eats the sea lice into the fish farm. Experts predict that sea lice extermination will be possible with convergence technologies, including old management means such as pesticides and new strategies such as genetic resistance culture, but the performance is not yet successful, and to date, the use of insecticides containing emamectin benzoate has been the most effective means.
[7] (Patent Document 1) KR1020010109335 A
DETAILED DESCRIPTION OF THE INVENTION
[Summary]
[8] The present invention provides a composition for preventing or treating an infectious disease caused by a fish parasite including sea lice, using a Sophora flavescens Aiton, which is a food material harmless to human body and environmentally friendly and without causing tolerance, toxicity and environmental pollution.
[9] It is another object of the present invention to control, insect and eliminate fish parasites by using a feed additive composition containing an extract of Sophora flavescens Aiton as an active ingredient.
[Technical Solution]
[10] The present invention provides a pharmaceutical composition for preventing or treating a fish parasitic infectious disease comprising an extract of Sophora flavescens Aiton or a fraction thereof as an active ingredient. The extract of Sophora flavescens Aiton is a leaf, stem, root, flower, fruit or whole of Sophora flavescens Aiton, and extracts include matrine, oxymatrine, anagyrine, sophoranol, cytisine, methylcytisine, kurarinone, xanthohumol, Noranhydroicaritin, isoanhydroicaritin, glucoluteolin, kaempferol-3-sophoroside, Heilsteine, and Heilsteine-4-rhamnosyl glucoside.
[11] The extract of Sophora flavescens Aiton according to the present invention can be obtained by ultrasonic extraction, hot water extraction or solvent extraction, but is not limited thereto.
[12] In the present invention, the fish parasite is selected from the group consisting of sea lice, Cymothoa Exigua, Ichthyophthirius multifiliis, Bivagina tai, Anisakiasis, Distoma, Tapeworm, Scutica, Benedenia or Anisakis Simplex, and preferably in the genus Lepeophtheirus or in the caligus, in the caligidae, and more preferably, it is sea lice, Lepeophtheirus salmonis or caligus rogercresseyi.
[13] In the present invention, fish can be collectively referred to as any fish to which the parasitic infectious disease according to the present invention can develop, and it is preferable to use salmon, trout, catfish, perch, tuna, halibut, arctic char, sturgeon, flounder, tonguefish, carp, tilapia, striped bass, eel, sea bream, yellow tail, amber jack, grouper, Korean rockfish, red sea bream, rock bream, flat fish, mackerel, sea bass, tuna blue-fin, black sea bream, yellow tail and goldstriped amberjack. It is also preferably, but not exclusively, aquaculture. It is preferably Salmonidae.
[14] The present invention also provides a feed additive composition for preventing or improving a fish parasitic infection comprising an extract of Sophora flavescens Aiton or a fraction thereof as an active ingredient.
[15] The present invention also provides a composition for the control or insecticides of a fish parasite comprising Sophora flavescens Aiton extract or a fraction thereof as an active ingredient.
[16] As another example, the present invention provides a method for preventing or treating parasitic infestation in a fish by injecting a composition comprising an extract of Sophora flavescens Aiton or a fraction thereof as an active ingredient into fish.
[Effects of the Invention]
The composition comprising the extract of Sophora flavescens Aiton of the present invention or the fraction thereof as an active ingredient may be used as a preventive or therapeutic agent for fish parasites because it induces sea lice to be avoided or the fish to inhibit or eliminate parasitic access at the time of ingestion.
BRIEF DESCRIPTION OF THE DRAWINGS
[18] Fig.1 shows a Y-tube chamber for sea lice avoidance experiments.
[19] Fig.2 shows the results of the sea lice avoidance effect of the extract of Sophora flavescens Aiton.
[20] Figures 3(a) and 3(b) show the death, blunting, and survival rate of sea lice in a concentration-dependent manner.
DETAILED DESCRIPTION
Sophora flavescens Aiton is a perennial plant belonging to the rosemary bean family of dicotyledonous plants and a wild flower native to the mountain areas of the country and Flowers bloom in raceme. The scientific name of Gosam is Sophorae flavescens Aiton, and the name Gosam uses the word 'Go' because the taste is bitter and use the letter 'Sam' because the efficacy is similar to ginseng. It’s roots are mainly used as medicines, and it has the effect of elimination of stroke, the cooling the heat of the body, the efficacy of taking urine out of it and extracting heat through it and the efficacy of cooling the heat and drying the moisture, and therefore, it is used for leukopenia treatment and anti-radioactivity, blood sugar lowering, antitumor, antibacterial, immunosuppression and so on.
[23] In the present invention, Sophorae flavescens Aiton is used as raw, or it is possible to use a Sophorae flavescens Aiton which has undergone more than one process through a drying method such as natural drying, oven drying, hot air drying, freeze drying, or a method such as juicing, grinding, cutting and crushing.
[24] The term “extract” in the present invention means an extract obtained by extracting the Sophorae flavescens Aiton, a diluent or concentrate of the extract, a dried product obtained by drying the extract, an adjusted product or a purified product of the extract, or a mixture thereof, and extracts of all formulations which can be formed using an extract.
[25] In the extract of Sophora flavescens Aiton of the present invention, the method for extracting Sophora flavescens Aiton is not particularly limited and may be carried out according to a method commonly used in the art. Non-limiting examples of the extraction method include hydrothermal extraction method, ultrasonic extraction method, filtration method, and reflux extraction method. These methods may be carried out singly or in combination of two or more methods.
[26] In the present invention, the kind of the extraction solvent used for extracting the Sophora flavescens Aiton is not particularly limited, and any solvent known in the art can be used. Non-limiting examples of the extraction solvent include water; C1 to C4 lower alcohols such as methanol, ethanol, propyl alcohol and butyl alcohol; Polyhydric alcohols such as glycerin, butylene glycol and propylene glycol; and hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane; or mixtures thereof, and preferably, water, lower alcohol, 1,3-butyleneglycol, and ethyl acetate may be used alone or in combination of two or more. In the present invention, the extract may be extracted with a solvent selected from the group consisting of water, an alcohol having 1 to 4 carbon atoms and a mixed solvent thereof, and the alcohol may be methanol, ethanol, propyl alcohol or butanol, but is not limited to.
[27] As a method for obtaining the extract of Sophora flavescens Aiton of the present invention, it is more preferable to dry the Sophora flavescens Aiton at a shade and a room temperature for 5 to 7 days after harvest, and to pulverize, and polar solvent of (C1) to (C4) lower alcohols such as water, methanol, ethanol, and butanol of about 1 to 20 times, preferably about 1 to 5 times, of the dry weight, or a mixed solvent thereof having a mixing ratio of about 1: 0.1 to 1:10 is used as an elution solvent, and the extraction temperature is 20 <o >C to 100 <o >C, preferably room temperature, and the extraction period can be extracted using extraction methods such as hot water extraction, cold extraction, reflux cooling extraction, or ultrasonic extraction for about 12 hours to 6 days, preferably 5 days.
[28] The term “fraction” in the present invention means the product obtained by performing fractionation to separate a specific component or a specific component group from a mixture containing various components.
[29] The fractionation method for obtaining the fraction in the present invention is not particularly limited and may be carried out according to a method commonly used in the art. As a non-limiting example of the above-mentioned fractionation method, there can be mentioned a method in which the extract obtained by extracting Sophora flavescens Aiton is treated with a predetermined solvent to obtain a fraction from the extract.
[30] In the present invention, the compounds contained in the extract of Sophora flavescens Aiton include matrine, oxymatrine, anagyrine, sophoranol, cytisine, methylcytisine, kaurinone, xanthohumol, Noranhydroicaritin, isoanhydroicaritin, glucoluteolin, kaempferol-3-sophoroside, Heilsteine, Heilsteine-4-rhamnosyl glucoside, and the like. And such compounds may be obtained from the extract or fraction by conventional separation and purification processes.
[32] In the present invention, fish can be collectively referred to as any fish to which the parasitic infectious disease according to the present invention can develop, and it is preferable to use salmon, trout, catfish, perch, tuna, halibut, arctic char, sturgeon, flounder, tonguefish, carp, tilapia, striped bass, eel, sea bream, yellow tail, amber jack, grouper, Korean rockfish, red sea bream, rock bream, flat fish, mackerel, sea bass, tuna blue-fin, black sea bream, yellow tail and goldstriped amberjack. It is also preferably, but not exclusively, aquaculture. In one embodiment of the present invention, an experiment was conducted using salmon as an example.
[33] The parasite of the present invention collectively refers to an invertebrate living in parasitic life outside and in the body of another organism (fish, crustacean, animal, plant, etc.). In detail, there are the sea lice, Cymothoa Exigua, Ichthyophthirius multifiliis, Bivagina tai, Anisakiasis, Distoma, Tapeworm, Scutica, Benedenia, Anisakis Simplex, and the like, but are not limited to. It also includes at least one of internal parasites (protozoa, annular animals, linear animals, etc.) and external parasites (flat animals, arthropods, etc.).
[34] In one embodiment of the present invention, it has been confirmed that the extract of Sophora flavescens Aiton has an effect of eliminating sea lice (FIGS.2 and 3), and therefore, it has been found that the composition comprising the extract of Sophora flavescens Aiton of the present invention is suitable for use in the prevention, improvement or treatment of parasitic infection of fish.
[35] The “prevention” in the present invention means any action to inhibit or delay the onset of parasitic infectious disease of fish by the composition, and “treatment” means any action whereby the symptoms of a parasitic infectious disease of a fish are improved or beneficially altered by the composition.
[36] The “pharmaceutical composition” in the present invention means a preparation for the purpose of prevention or treatment of disease, and may be formulated into various forms according to conventional methods. For example, it can be formulated into oral formulations such as powders, granules, tablets, capsules, suspensions, emulsions and syrups, and can be formulated in the form of external preparations, suppositories, and sterilized injection solutions. However, it is most preferable that the composition of the present invention is provided in the form of a bathing agent for the purpose of treating diseases of fishes.
[37] In addition, each of the formulations may be further formulated with pharmaceutically acceptable carriers such as buffers, preserving agents, wettability agents, solubilizers, isotonic agents, stabilizers, bases, excipients, lubricants and the like known in the art.
[38] Meanwhile, the pharmaceutical composition of the present invention is administered in a pharmaceutically effective amount. The “ pharmaceutically effective amount” of the present invention means an amount that is sufficient to treat a disease at a reasonable benefit / risk ratio applicable to veterinary treatment and does not cause side effects, and “effective dose levels” may be determined by factors including the health of a fish, severity, activity of the drug, sensitivity to the drug, method of administration, time of administration, route of administration and rate of release, duration of treatment, composition or factors including co-administered drugs and other factors well known in the veterinary arts.
[40] In another aspect, the present invention provides a feed additive composition for preventing or improving a parasitic infestation disease of fish, comprising an extract of Sophora flavescens Aiton, a fraction thereof, or a compound isolated therefrom as an active ingredient.
[42] For the purpose of the present invention, the extract of Sophora flavescens Aiton, fractions thereof, or compounds isolated therefrom can be added to feed compositions as a feed additive, since they can be used for the purpose of preventing or improving a parasitic infectious disease of fish.
[43] In the present invention, the feed additives are collectively referred to as substances added to feed in small quantities for nutritive or specific purposes, therefore, in the present invention, the feed additives are substances added for the purpose of preventing or improving parasitic infectious diseases of fish. The extract of Sophora flavescens Aiton of the present invention or the compound isolated therefrom may be included in the feed composition as the feed additive, and the feed may be used to collectively mean all the foods supplied to the fish.
[44] The feed composition of the present invention may further contain a binder, an emulsifying agent, a preservative, etc. to be added for the purpose of preventing deterioration of quality, and may further contain an amino acid, a vitamin, an enzyme, a prophylactic agent, a flavoring agent, a non-protein nitrogenous substance, a silicate, a buffer, a colorant, an extractant, an oligosaccharide and the like for the purpose of enhancing the utility, and in addition, feed mixtures and the like may be further included, but the present invention is not limited thereto.
[45] The compound feed commonly used in the feed composition for fish includes at least one protein source selected from fish meal, casein, meat meal, and shrimp powder, or at least one carbohydrate source selected from sweet potato starch, potato starch, wheat starch, or at least one lipid source selected from rapeseed oil, soybean oil, corn oil, pollack liver oil, squid liver oil,
but the present invention is not limited thereto, and even when used in combination with the compounded feed, the effect of preventing or improving the parasitic infectious disease described in the present invention occurs in the same manner.
[46] In another aspect, the present invention provides a method for preventing or treating parasitic infestation in a fish, comprising the step of administering a composition comprising the extract of Sophora flavescens Aiton, a fraction thereof or a compound isolated therefrom as an active ingredient directly to a fish or to a fish farm.
[47] In another aspect, the present invention provides a method for preventing or treating parasitic infestation in fish, comprising the step of administering to a fish directly or in a fish farm a pharmaceutical composition or feed additive composition comprising an extract of Sophora flavescens Aiton as an active ingredient.
[48] The method for preventing or treating a parasitic infectious disease of fish may include any step directly or indirectly delivered to a fish by including the step of administering directly to the fish or to a farm.
[49] Specifically, for example, the purpose of the present invention can be achieved by directly injecting or feeding to a fish, and can also be accomplished through means such as bathing or eating. Preferably, the effective concentration of the composition may be coated on the feed and fed to a fish having lesions due to parasitic infectious disease, but the present invention is not limited thereto. At this time, the dose of the composition may vary depending on the weight of the fish to be treated, the health condition, the administration time, and the severity of the disease.
[51] Hereinafter, effects of the present invention will be described with reference to examples.
[53] [Example 1]: Preparation of extract of Sophora flavescens Aiton
[54] The roots were thoroughly washed with water, naturally dried for 5 to 7 days, and cut. Three times the weight of methanol was added to 50 kg of the excised Sophora flavescens Aiton, and the mixture was extracted at room temperature for 5 days and then filtered. It was concentrated under reduced pressure, lyophilized and powdered.
[56] [Example 2]: Sea lice (avoidance) repellent effect of Sophora flavescens Aiton [57] Using the Y-Tube choice camber, the movement of the sea lice and the time spent in each section were measured to confirm the avoidance effect of the sea lice repellent.
[58] The control section is flushed with clean sea water and the compound section is flushed with the substance to be tested. Mixed section is a section where control and compound sections are mixed and drained.
[59] The sea lice are positioned at the point where the mixed section starts and the movement is observed, and the analysis of the test results confirmed the effect of sea lice eradication by analyzing how long the sea lice moved and stayed in the opposite direction of flow of the test material, that is, the control section and the mixed section.(see Fig.1)
[61] According to the above experimental method, the movement of the sea lice was observed by flowing the seawater in the control section and flowing the substance of the present invention in the compound section, as shown in FIG.2.
[62] In Fig.2, Con.1 was treated with seawater as a control, OH4_A was treated with 0.5 mg / ml of Sophora flavescens Aiton and OH4_B was treated with 0.25 mg / ml of Sophora flavescens Aiton respectively and therefore it shows the effect of avoiding sea lice. In Con.1, the sea lice did not move to other sections because the seawater flows in all sections of the Y-tube chamber, and the time spent of sea lice in OH4_A treated with 0.5 mg / ml Sophora flavescens Aiton was about 68% in the control section, about 20% in the mixed section, and about 12% in the compound section, and the time spent of sea lice in OH4_B treated with 0.25 mg / ml of Sophora flavescens Aiton was about 29% in the control section, about 24% in the mixed section, and about 47% in the compound section. This means that it has sea lice avoidance effect depending on the concentration of Sophora flavescens Aiton.
[64] [Example 3]: The survival rate of sea lice about Sophora flavescens Aiton.
[65] In order to confirm the effectiveness of Sophora flavescens Aiton that the sea lice had a repelling effect, experiments were carried out using a 24-well plate. Sea water, sea lice and active substances were added to the 24-well plate at various concentrations, and then incubated in an incubator, and all solutions used in the experiments were kept at 10 ° C during the experiment. After incubation for 24 hours, the effect of sea lice was confirmed by observing the condition of sea lice.
[67] As a result of the experiment, as shown in Fig. 3 (a), about 95% of the sea lice survive in the control without any treatment, but as the treatment concentration of extract of Sophora flavescens Aiton increased, the number of alive species decreased and the number of dead species increased. In addition, when the concentration of extract of Sophora flavescens Aiton was 0.31 mg / ml, 50% (LD50) of the sea lice population was dead, and at 0.12 mg / ml, the sea lice population 50% (EC50) showed moribund state or swimming inhibition and showed excellent effect on sea lice.
[69] In conclusion, the extract of Sophora flavescens Aiton of the present invention or its fractions thereof have anti-sea lice activity, and thus can be used for the prevention or treatment of parasitic infectious diseases of fish, for the parasite elimination, and for the control thereof.
[INDUSTRIAL APPLICABILITY]
The present invention is recognized as being industrially applicable in the fields of pharmaceutical biotechnology and agriculture and fisheries.
Claims (12)
1. A pharmaceutical composition for preventing or treating a fish parasitic infectious disease comprising an extract of Sophora flavescens Aiton or a fraction thereof as an active ingredient.
2. The pharmaceutical composition according to claim 1, wherein the extract of Sophora flavescens Aiton is leaf, stem, root, fruit or whole of Sophora flavescens Aiton.
3. The pharmaceutical composition according to claim 1, wherein the the extract of Sophora flavescens Aiton comprises at least one compound selected from the group consisting of matrine, oxymatrine, anagyrine, sophoranol, cytisine, methylcytisine, kaurinone, xanthohumol, Noranhydroicaritin, isoanhydroicaritin, glucoluteolin, kaempferol-3-sophoroside, Heilsteine, and Heilsteine-4-rhamnosyl glucoside.
4. The pharmaceutical composition according to claim 1, wherein the extract of Sophora flavescens Aiton is subjected to ultrasonic extraction, hot water extraction or solvent extraction.
5. The pharmaceutical composition according to claim 1, wherein the fish parasite is sea lice, Cymothoa Exigua, Ichthyophthirius multifiliis, Bivagina tai, Anisakiasis, Distoma, Tapeworm, Scutica, Benedenia or Anisakis Simplex.
6. The pharmaceutical composition according to claim 1, wherein the fish parasite is caligidae.
7. The pharmaceutical composition according to claim 1, wherein the fish parasite is of the genus Lepeophtheirus or of the genus Caligus.
8. The pharmaceutical composition according to claim 7, wherein the fish parasite is Lepeoptheirus salmonis or caligus rogercresseyi.
9. The pharmaceutical composition according to claim 1, wherein the fish is Salmonidae.
10. A feed additive composition for preventing or improving a fish parasitic infection comprising the extract of Sophora flavescens Aiton or fraction thereof as an active ingredient.
11. A composition for the control of fish parasites or insecticides comprising the extract of Sophora flavescens Aiton or fraction thereof as an active ingredient.
12. A method for preventing or treating a parasite infestation of a fish by injecting a composition containing the extract of Sophora flavescens Aiton or fraction thereof as an active ingredient into fish.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2018/001249 WO2019146826A1 (en) | 2018-01-29 | 2018-01-29 | Composition for preventing or treating parasitic infections in fish, comprising sophora flavescens aiton extract or fraction thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20181070A1 true NO20181070A1 (en) | 2018-08-14 |
| NO345471B1 NO345471B1 (en) | 2021-02-22 |
Family
ID=67396128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20181070A NO345471B1 (en) | 2018-01-29 | 2018-01-29 | Pharmaceutical compositions for preventing or treating a sea lice disease comprising an extract of Sophora flavescens Aiton or fractions thereof. |
Country Status (4)
| Country | Link |
|---|---|
| CA (1) | CA3088618C (en) |
| GB (1) | GB2583664B (en) |
| NO (1) | NO345471B1 (en) |
| WO (1) | WO2019146826A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113499337B (en) * | 2021-08-11 | 2023-04-28 | 江苏海洋大学 | Application of kurarinone in preparation of aquatic pathogenic bacteria resistant medicines or feed additives |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4608255B2 (en) * | 2004-07-15 | 2011-01-12 | 日本水産株式会社 | Composition having anti-parasitic activity for fish and method for preventing / treating parasitic disease |
| CN101040936B (en) * | 2007-04-28 | 2011-10-19 | 大连水产学院 | Compound Chinese traditional medicine agent for preventing fish verminosis |
| KR101006556B1 (en) * | 2007-12-20 | 2011-01-07 | 주식회사 바이넥스 | Anti-bacterial compositions against Streptococcus |
| CN101690767B (en) * | 2009-09-29 | 2012-08-08 | 北京大北农动物保健科技有限责任公司 | Compound pesticide for fishing and preparation method and application thereof |
| KR101207276B1 (en) * | 2010-04-14 | 2012-12-13 | 대한민국 | Feed additives using Sophora flavescens Ait and Feed for raising fishes including the same |
| JP5954252B2 (en) * | 2012-05-16 | 2016-07-20 | 信越化学工業株式会社 | Resist material and pattern forming method using the same |
| CN103877459A (en) * | 2012-12-20 | 2014-06-25 | 青岛中仁药业有限公司 | Compound Chinese herbal medicine capable of treating grass carp ichthyophthirius multifiliis and its production method |
| CN105029014A (en) * | 2015-07-08 | 2015-11-11 | 滁州市南谯区瑞琳水产养殖专业合作社 | Pine needle soft feed for reducing fish dermatopathy and preparation method thereof |
| KR101813078B1 (en) * | 2015-10-27 | 2017-12-29 | (주)나리소 | Insecticide Composition Containing Plant Extracts as Active Ingredients |
| CN105232850A (en) * | 2015-11-11 | 2016-01-13 | 郑州后羿制药有限公司 | Chinese herbal medicine fermentative extracting solution for preventing and controlling parasitic diseases of freshwater fish and preparation method thereof |
| CN106265628B (en) * | 2016-07-18 | 2018-12-14 | 暨南大学 | Sophoraflavanone G kills the application in fish epizoite infusorian drug in preparation |
| CN106038682A (en) * | 2016-07-18 | 2016-10-26 | 暨南大学 | Chinese herbal medicine compound preparation for preventing and treating chthyophthirius multifilis for fish as well as preparation and application of Chinese herbal medicine compound preparation |
| KR101769074B1 (en) * | 2017-03-30 | 2017-08-17 | 허운덕 | Compositions for repelling fur and feather, and vermin comprising sophora extract as active ingredients |
-
2018
- 2018-01-29 NO NO20181070A patent/NO345471B1/en unknown
- 2018-01-29 WO PCT/KR2018/001249 patent/WO2019146826A1/en active Application Filing
- 2018-01-29 GB GB2010954.2A patent/GB2583664B/en active Active
- 2018-01-29 CA CA3088618A patent/CA3088618C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3088618C (en) | 2023-10-03 |
| NO345471B1 (en) | 2021-02-22 |
| WO2019146826A1 (en) | 2019-08-01 |
| GB202010954D0 (en) | 2020-09-02 |
| CA3088618A1 (en) | 2019-08-01 |
| GB2583664A (en) | 2020-11-04 |
| GB2583664B (en) | 2022-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220039429A1 (en) | Supplemented fish feed | |
| Higashi | Vitamins in fish-with special reference to edible parts | |
| CA3088618C (en) | Compositions for preventing or treating fish parasitic infections, including extracts of sophora flavescens aiton or fractions thereof | |
| KR101872435B1 (en) | Composition for preventing or treating parasitization in fishes comprising sophora flavescens aiton extract | |
| KR101913089B1 (en) | Composition for preventing or treating parasitization in fishes comprising jerusalem artichoke extract | |
| WO2019146827A1 (en) | Composition for preventing or treating parasitic infections in fish, comprising helianthus tuberosus extract and sophora flavescens aiton extract | |
| JP2000281568A (en) | Agent for preventing and curing parasite | |
| KR101877845B1 (en) | Composition for preventing or treating parasitization in fishes comprising jerusalem artichoke and sophora flavescens aiton extract | |
| WO2019146825A1 (en) | Composition for preventing or treating parasitic infections in fish, comprising jerusalem artichoke extract or fraction thereof | |
| JP2006061107A (en) | Parasitic disease inhibitor, feed for marine cultured fishes and method for preventing parasitic disease of marine cultured fishes | |
| Maran et al. | Fish Diet, Health and Control in Aquaculture | |
| KR100608153B1 (en) | Method of rearing and feeds | |
| KR101866286B1 (en) | A feed composition for preventing or treating parasitic infectious disease of fish comprising Reynoutria japonica extract | |
| KR102428964B1 (en) | Antimicrobial composition comprising the extracts of hermetia illucens | |
| WO2024092098A1 (en) | Compositions and methods for the management of pests in aquaculture systems | |
| WO2024092107A1 (en) | Compositions and methods for targeting reproduction in pests present in aquaculture systems | |
| WO2024092103A1 (en) | Compositions and methods for the management of pests in farmed fish ecosystems | |
| WO2024092113A1 (en) | Compositions and methods for the targeted management of pest infections in fish populations with a neem extract rich in azadirachtin a | |
| KR101935454B1 (en) | A feed composition for preventing or treating flatfish-viral hemorrhagic septicemia comprising Reynoutria japonica extract | |
| JP2016013122A (en) | Feed for aquatic organism and culture method | |
| AL-FAISAL et al. | Identification of Cypriniodontiformes fishes from Al-Hammar marsh, south of Iraq | |
| WO2024092140A1 (en) | Compositions and methods for the management of pest co-infections in aquaculture systems | |
| WO2024092111A1 (en) | Pest control agent-infused fish feed | |
| WO2024092124A1 (en) | Compositions and methods for the management of non-copepod parasitic disease in aquaculture systems | |
| KR20200004013A (en) | Antimicrobial composition comprising the hexane and butanol fractions of teleogryllus emma extract |